Status:
COMPLETED
TES for the Treatment of RP
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Oxford University Hospitals NHS Trust
Moorfields Eye Hospital NHS Foundation Trust
Conditions:
Retinitis Pigmentosa
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Retinitis pigmentosa (RP) is a progressive degenerative disease of the retina, which often leads to blindness. 1 in 4000 people in the UK are affected by RP yet there is no established therapy for tre...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study
- Male or Female, 18 or more years of age
- Diagnosis of retinitis pigmentosa (rod-cone dystrophy) made by an ophthalmologist
- Participants should have a visual acuity of ≥ 0.02 (Snellen Chart)
- Able (in the investigators opinion) and willing to comply with all study requirements
- Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study
- Participants, or a designated other, should have sufficient motor skills (assessed by the investigator) to apply the device independently
Exclusion
- Female participants who are pregnant, lactating or planning pregnancy during the course of the study
- Diabetic Retinopathy
- Previous arterial or venous occlusion of the retina
- Previous retinal detachment
- Previous silicone oil tamponade
- Dry or exudative age-related macular degeneration
- Macular oedema
- All forms of glaucoma
- Any form of corneal degeneration that reduces visual acuity
- Neovascularisation of any origin
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study
- Forms of mental illness related to bipolar affective and schizoid-affective disorders, and all forms of dementia
- Simultaneous participation in another interventional study or history of interventions where effects may still persist
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01847365
Start Date
April 1 2013
End Date
February 1 2015
Last Update
November 13 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford University Hospitals NHS Trust
Oxford, Oxfordshire, United Kingdom, OX3 9DU
2
Moorfields Eye Hospital NHS Foundation Trust
London, United Kingdom, EC1V 2PD